Intravitreal Bevacizumab Appears Safe For Pregnant Women

Wednesday, October 27, 2010

Comments

Ocular surgery News

Intravitreal bevacizumab for off-label ocular indications appeared safe and effective in pregnant patients with choroidal neovascularization unrelated to age-related macular pathologies, a study showed.

Full Story

Retina Products and Equipment »

All of the following drugs are FDA approved for the treatment of predominantly classic subfoveal CNV in patients with neovascular AMD except for which one?
1. Pegaptanib sodium (Macugen)
2. Verteporfin (Visudyne PDT)
3. Ranibizumab (Lucentis)
4. Bevacizumab (Avastin)
5. All of the above
Check The Answer

CIRRUS™ HD-OCT 5000 with FastTrac™ - The Clinical Powerhouse
CIRRUS HD-OCT 5000 is configured with ... view product
Selecta Trio™ YAG Laser, SLT and Photocoagulation
The Lumenis Selecta® Trio™ ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

Intravitreal Bevacizumab Appears Safe For Pregnant Women

Comments

Related Categories

Retina Products and Equipment »

Quick Quiz

All of the following drugs are FDA approved for the treatment of predominantly classic subfoveal CNV in patients with neovascular AMD except for which one?

AdGlare RMR Ad

Featured Products

CIRRUS™ HD-OCT 5000 with FastTrac™ - The Clinical Powerhouse

Selecta Trio™ YAG Laser, SLT and Photocoagulation

Follow OphthalmologyWeb

AdGlare RMR2

Write for Us